# How is a developmental-AI tool regulated by CDSCO, FDA and EU MDR? Canonical: https://pinnacleblooms.org/ask/how-is-a-developmental-ai-tool-regulated-by-cdsco-fda-and-eu-mdr Publisher: Pinnacle Blooms Network / Bharath Healthcare Laboratories Private Limited A developmental-AI tool is regulated by intended use and risk class: CDSCO treats clinical SaMD under the Medical Device Rules 2017 (Class A–D), the FDA applies risk-based SaMD oversight under the FD&C Act, and the EU MDR classifies software chiefly via Rule 11. Tools that screen and route without diagnosing may sit at a lower risk tier. AbilityScore® is part of Pinnacle’s developmental assessment. Diagnosis, where needed, requires an appropriately qualified healthcare professional. *A developmental-AI tool earns the right to support a child's care by clearing the same regulatory bars as any medical software — and by being honest about where its claims begin and end.* ## In short A developmental-AI tool is regulated according to its **intended use and risk class**. In India, the **CDSCO** treats clinically-purposed Software as a Medical Device (SaMD) under the Medical Device Rules, 2017; in the United States, the **FDA** evaluates it as SaMD under the FD&C Act and its digital-health framework; in the European Union, the **EU MDR (2017/745)** classifies it via Rule 11 for software. A tool that only supports or screens — without making a diagnostic claim — may sit *outside* the SaMD boundary, but the moment it informs clinical decisions it falls squarely within these regimes. ## How each regime treats developmental AI - **CDSCO (India)** — Under the Medical Devices Rules, 2017, software with a medical purpose is risk-classified A–D. A developmental screening or assessment-support tool typically lands in **Class A or B (low–moderate risk)**, requiring registration, a quality management system, and clinical evidence proportionate to its claims. Pinnacle's AbilityScore® is referenced as **CDSCO Class B SaMD**. - **FDA (United States)** — The FDA assesses whether software meets the device definition, then applies risk-based oversight (510(k), De Novo, or enforcement discretion for lower-risk wellness or clinical-decision-support tools). Its **Predetermined Change Control Plan** framework is central for AI/ML tools that learn or update over time. - **EU MDR (European Union)** — Standalone medical software is classified chiefly under **Rule 11**, which tends to push diagnostic and decision-driving software into **Class IIa or higher**, demanding a Notified Body conformity assessment, clinical evaluation, and post-market surveillance. Across all three, the determining question is the **claim**: a tool that *screens, monitors and routes* a child to a clinician carries lighter obligations than one that *diagnoses*. Transparency about training data, performance, bias mitigation and human oversight is now expected everywhere. ## Where a support tool sits Many developmental-AI tools are deliberately scoped as **screening and triage aids that never replace clinical judgement** — they flag what merits a closer look and route families to qualified clinicians. This keeps them in a lower-risk tier while preserving child safety, because the diagnostic decision always rests with a human professional in a regulated setting. ## The Pinnacle way AbilityScore® is part of Pinnacle’s developmental assessment. Diagnosis, where needed, requires an appropriately qualified healthcare professional — never from an algorithm alone. The AbilityScore® is a clinician-administered structured assessment, registered as **CDSCO Class B SaMD**, built on 2.5 billion+ data points and 25 million+ therapy sessions, and protected by 16+ WIPO PCT patents with 12 validated studies behind it. Explore the [Pinnacle network](/), understand [what the AbilityScore® is and how it is administered](/ask/what-is-the-abilityscore-and-how-is-it-calculated), and see how it connects to [speech therapy](https://www.pinnacleblooms.org/top-speech-therapy-center-india-proven-improvement-rate) and family-facing care. ## Trusted sources WHO guidance on the classification of digital health interventions; CDSCO Medical Devices Rules framework for Software as a Medical Device; US FDA digital-health and SaMD oversight resources; EU MDR (Regulation 2017/745) software classification under Rule 11. **Next step —** Evaluating a developmental-AI tool for clinical or institutional use? [Contact the Pinnacle regulatory and clinical team](/) to discuss SaMD scope, evidence and safe deployment. This is general information, not a diagnosis — individual assessment and diagnosis require an appropriately qualified healthcare professional. ## Sources - WHO — classification of digital health interventions: https://www.who.int - NICE — evidence standards for digital health technologies: https://www.nice.org.uk ## Connected topics and perspectives - Professional: https://pinnacleblooms.org/ask/lens/stakeholder/professional - Support: https://pinnacleblooms.org/ask/lens/intent/support - Plan: https://pinnacleblooms.org/ask/lens/lifecycle/plan - About: https://pinnacleblooms.org/ask/lens/route/about ## Related question paths ### Understand the subject - What is the clinical and regulatory basis of AbilityScore®?: https://pinnacleblooms.org/ask/what-is-the-clinical-and-regulatory-basis-of-abilityscore - What is the clinical and regulatory basis of TherapeuticAI®?: https://pinnacleblooms.org/ask/what-is-the-clinical-and-regulatory-basis-of-therapeuticai ### Explore therapy & support - What is Software as a Medical Device (SaMD) in child health?: https://pinnacleblooms.org/ask/what-is-software-as-a-medical-device-samd-in-child-health - How do you build software for tracking child development?: https://pinnacleblooms.org/ask/how-do-you-build-software-for-tracking-child-development - How is AI used in child developmental assessment?: https://pinnacleblooms.org/ask/how-is-ai-used-in-child-developmental-assessment - What data-privacy rules apply to children's health data in India?: https://pinnacleblooms.org/ask/what-data-privacy-rules-apply-to-children-s-health-data-in-india